Evidence map›Paper›PMID 32055601›Full record

ArticleAnnals of translational medicine2020

Phenotypic characterization of CADASIL patients with the Arg332Cys mutation in the

Chen-Si Li, Tian-Wei Wang, Jie Wang, Shuai-Hong Li, Na Li, Xiao-Shuang Wang, Le Fang

Open access · diamondAbstract read
In one paragraph

Article in Annals of translational medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Detecting a NovelMolecular syndromology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Chen-Si LiDepartment of Neurology, China-Japan Union Hospital of Jilin University, Changchun 130000, China.
Tian-Wei WangDepartment of Radiology, China-Japan Union Hospital of Jilin University, Changchun 130000, China.
Jie WangDepartment of Neurology, China-Japan Union Hospital of Jilin University, Changchun 130000, China.
Shuai-Hong LiDepartment of Neurology, China-Japan Union Hospital of Jilin University, Changchun 130000, China.
Na LiDepartment of Neurology, China-Japan Union Hospital of Jilin University, Changchun 130000, China.
Xiao-Shuang WangDepartment of Neurology, China-Japan Union Hospital of Jilin University, Changchun 130000, China.
Le FangDepartment of Neurology, China-Japan Union Hospital of Jilin University, Changchun 130000, China.
Union Hospital · CNUnion Hospital · CNJilin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a hereditary vascular disease caused by mutations in

methodsA case study and the results of a comprehensive systemic search of the PubMed database, using the keywords "CADASIL", "Arg332Cys", "R332C", and "exon 6", are reported. The results obtained, combined with the data obtained from the largest published case series on CADASIL, the clinical and imaging characteristics of patients with the Arg332Cys mutation, were compared and analyzed.

resultsA 48-year-old woman with a rare Arg332Cys mutation in exon 6 of

conclusionsCADASIL patients with the Arg332Cys mutation in exon 6 have been reported in Europe and Asia. The majority of patients had early disease onset. Diffuse high signals involving the external capsule, brainstem, and bilateral temporal pole are the main neuroimaging characteristics.

Indexed as

Arg332CysCerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)exon 6

Identifiers

PMID32055601
PMCPMC6995735
OpenAlexW2997150909

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.